Related Experiment Videos

[Long-term follow-up of the Hancock prostheses]

F Fernández Vázquez1, J Verdejo París, J L Cervantes Escárcega

  • 1Instituto Nacional de Cardiología Ignacio Chávez, México, D.F.

Archivos Del Instituto De Cardiologia De Mexico
|March 1, 1991
PubMed

Insights

This study followed Hancock bioprostheses for 12.8 years, finding a 48.18% dysfunction rate. Half of patients with prosthetic dysfunction required re-operation, highlighting long-term cardiac valve performance concerns.

Area of Science:

  • Cardiovascular Surgery
  • Biomaterials Science
  • Medical Device Performance

Context:

  • Hancock bioprostheses are commonly used for heart valve replacement.
  • Long-term outcomes and durability of bioprosthetic valves are critical for patient management.
  • Understanding failure modes is essential for improving future prosthetic designs.

Purpose:

  • To evaluate the long-term clinical outcomes and dysfunction rates of Hancock bioprostheses.
  • To assess the histopathological findings in explanted Hancock bioprostheses.
  • To compare the performance of Hancock bioprostheses with data from the literature.

Summary:

  • A 12.8-year follow-up of 128 Hancock bioprostheses revealed a cumulative dysfunction rate of 48.18%.
  • The annual dysfunction rate was calculated at 3.34% +/- 1.3%.
  • Histopathological analysis was performed on 17 explanted prostheses, and 50% of patients with dysfunction underwent re-operation.

Impact:

  • Provides crucial data on the long-term durability of Hancock bioprostheses.
  • Informs clinical decision-making regarding the choice between biological and mechanical prostheses.
  • Contributes to the understanding of bioprosthetic valve degeneration mechanisms.

Related Concept Videos